Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Insecticides (India) Ltd (INSECTICID)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532851 NSE: INSECTICID Pesticides & Agrochemicals | Small Cap | Insecticides India Share Price
₹604.30 -6.40 (-1.05%)
As on 11-Sep'26 16:59
Insecticides (India) Ltd (INSECTICID)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532851 NSE: INSECTICID Pesticides & Agrochemicals | Small Cap | Insecticides India Share Price
₹604.30 -6.40 (-1.05%)
As on 11-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹1,758 Cr.
Current Price
₹604.3
52-Week Low / High
₹526 / 800
TTM EPS
₹43
TTM Sales
₹2,060 Cr.
Book Value per Share
₹434.4
P/E Ratio
14.05
Lower than its 5-year historical median
Industry PE
29
Price to Book (P/B)
1.39
Lower than its 5-year historical median
Price to Sales (P/S)
0.85
Lower than its 5-year historical median
EV/EBITDA
8.12
Lower than its 5-year historical median
Dividend Yield
0.33%
Profitability Efficiency
Return on Equity (ROE)
12.10%
Underperforms industry median
Return on Capital Employed (ROCE)
15.97%
In line with industry median
Return on Assets (ROA)
6.81%
Operating Profit Margin
11.2%
Net Profit Margin
6.51%
Gross Profit Margin
9.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
7.09%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
2.64%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-1.84%
Asset Quality
Promoter Holding
72.30%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,235 Cr.
Equity
₹29.1 Cr.
Face Value
₹10
All Time Low / High
₹11.76 / 1096.30
Check Before You Invest
Quality
Very GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Insecticides (India) Ltd a good quality company?
Insecticides (India) Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Insecticides (India) Ltd performance compare with that of its Peers?
Revenue growth of Insecticides (India) Ltd vs industry peers?
Insecticides (India) Ltd revenue CAGR is 8.59%, compared to the industry median CAGR of 7%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Insecticides (India) Ltd?
Promoters hold 72.30% of the Insecticides (India) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Insecticides (India) Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 6.9% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Insecticides (India) Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 15.6% | 19.7% | 20.7% | 14.3% | 13.7% | 16.1% | 9.8% | 13.2% | 17.3% | 15.7% | - |
| Value Creation Index ⓘ | 0.1 | 0.4 | 0.5 | 0.0 | 0.0 | 0.2 | -0.3 | -0.1 | 0.2 | 0.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,002 | 2,144 | 2,069 |
| Sales YoY Gr. | - | 8% | 11.2% | 14.2% | 4.2% | 5.9% | 19.8% | 9.2% | 1.8% | 7.1% | - |
| Adj EPS ⓘ | 17.8 | 27.5 | 40.5 | 29 | 31.4 | 36.1 | 23.9 | 33.4 | 48.1 | 47.1 | 41.4 |
| YoY Gr. | - | 54.1% | 47.3% | -28.5% | 8.6% | 14.7% | -33.7% | 39.6% | 44% | -2% | - |
| BVPS (₹) ⓘ | 149.9 | 176.6 | 213.3 | 235.6 | 264 | 293 | 309.4 | 341.6 | 371.8 | 417.2 | 431.6 |
| Adj Net Profit ⓘ | 55.3 | 85.2 | 126 | 89.8 | 97.4 | 107 | 70.8 | 98.8 | 140 | 137 | 120 |
| Cash Flow from Ops. ⓘ | 4 | 182 | -133 | 242 | 155 | 135 | -10.6 | 185 | 94.6 | 109 | - |
| Debt/CF from Ops. ⓘ | 59 | 0.6 | -2.3 | 0.8 | 0.6 | 0.4 | -15 | 0.5 | 1.1 | 1.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 8.9% | 8.6% | 6% | 7.1% | ||||
| Adj EPS ⓘ | 11.4% | 8.4% | 25.3% | -2% | ||||
| BVPSⓘ | 12.1% | 9.6% | 10.5% | 12.2% | ||||
| Share Price | 6.8% | 4.2% | 8.1% | -21.8% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 12.7 | 16.8 | 20.8 | 12.9 | 12.6 | 12.7 | 7.9 | 10.3 | 13.4 | 11.9 | 9.8 |
| Op. Profit Mgn % ⓘ | 11.2 | 13.9 | 16.1 | 11.8 | 10.8 | 11.4 | 7.4 | 8.3 | 11.1 | 10.8 | 9.8 |
| Net Profit Mgn % ⓘ | 5.6 | 7.9 | 10.5 | 6.6 | 6.9 | 7.1 | 3.9 | 5 | 7 | 6.4 | 5.8 |
| Debt to Equity ⓘ | 0.5 | 0.2 | 0.5 | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 238 | 221 | 258 | 249 | 232 | 232 | 214 | 211 | 221 | 226 | 127 |
| Cash Conv. Cycle ⓘ | 119 | 101 | 144 | 122 | 116 | 109 | 111 | 100 | 102 | 99 | 62 |
Valuation of Insecticides India - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,140 |
| Operating Expenses ⓘ + | 883 | 925 | 1,006 | 1,207 | 1,268 | 1,334 | 1,679 | 1,804 | 1,779 | 1,913 |
| Operating Profit ⓘ | 111 | 148 | 187 | 156 | 152 | 170 | 122 | 162 | 221 | 227 |
| Operating Profit Margin (%) | 11.2% | 13.8% | 15.7% | 11.4% | 10.7% | 11.3% | 6.8% | 8.3% | 11.1% | 10.6% |
| Other Income ⓘ + | 7 | 3 | 1 | 3 | 8 | 4 | 1 | 9 | 7 | 12 |
| Interest ⓘ | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 17 |
| Depreciation ⓘ | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 35 |
| Profit Before Tax ⓘ | 82 | 118 | 153 | 110 | 120 | 141 | 84 | 132 | 193 | 187 |
| Tax ⓘ | 23 | 34 | 31 | 24 | 26 | 34 | 21 | 30 | 51 | 47 |
| Profit After Tax | 59 | 84 | 122 | 86 | 94 | 107 | 63 | 102 | 142 | 139 |
| PAT Margin (%) | 6.0% | 7.8% | 10.3% | 6.3% | 6.6% | 7.1% | 3.5% | 5.2% | 7.1% | 6.5% |
| Adjusted EPS (₹) | 19.3 | 27.2 | 39.6 | 28.0 | 30.3 | 36.3 | 21.4 | 34.5 | 48.8 | 47.9 |
| Dividend Payout Ratio (%) | 6.90% | 4.90% | 3.40% | 14.30% | 4.40% | 5.50% | 14.10% | 8.70% | 4.10% | 4.20% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 464 | 548 | 662 | 732 | 820 | 870 | 918 | 1,012 | 1,085 | 1,220 | |
| Debt + | 221 | 105 | 296 | 185 | 94 | 47 | 157 | 72 | 87 | 131 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 199 | 243 | 280 | 247 | 362 | 324 | 448 | 420 | 508 | 439 | |
| Others Liabilities ⓘ | 111 | 129 | 150 | 153 | 181 | 191 | 194 | 249 | 325 | 297 | |
| Total Liabilities ⓘ | 995 | 1,026 | 1,388 | 1,317 | 1,457 | 1,432 | 1,718 | 1,752 | 2,005 | 2,088 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 185 | 232 | 240 | 239 | 239 | 253 | 262 | 283 | 279 | 366 | |
| CWIP ⓘ | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 130 | |
| Investments ⓘ | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 29 | |
| Inventories | 426 | 407 | 705 | 519 | 661 | 630 | 862 | 807 | 886 | 780 | |
| Trade Receivables | 212 | 235 | 244 | 320 | 255 | 289 | 296 | 297 | 385 | 487 | |
| Cash Equivalents | 9 | 20 | 9 | 74 | 83 | 36 | 20 | 61 | 57 | 87 | |
| Others Assets ⓘ | 95 | 99 | 158 | 114 | 148 | 117 | 138 | 139 | 207 | 208 | |
| Total Assets ⓘ | 995 | 1,026 | 1,388 | 1,317 | 1,457 | 1,432 | 1,718 | 1,752 | 2,005 | 2,088 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 | 100 |
| Cash Flow From Investing Activity ⓘ + | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 | -86 |
| Cash Flow From Financing Activity ⓘ + | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 | 18 |
| Net Cash Flow ⓘ | -0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 | 31 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 13.63 | 16.59 | 20.24 | 12.35 | 12.1 | 12.71 | 7.07 | 10.58 | 13.55 | 12.1 |
| ROCE (%) | 15.55 | 19.66 | 20.65 | 14.24 | 13.74 | 16.13 | 9.75 | 13.15 | 17.52 | 15.97 |
| Asset Turnover Ratio | 1.11 | 1.21 | 1.08 | 1.12 | 1.14 | 1.14 | 1.26 | 1.27 | 1.19 | 1.16 |
| PAT to CFO Conversion(x) | 0.07 | 2.17 | -1.09 | 2.81 | 1.65 | 1.26 | -0.17 | 1.83 | 0.65 | 0.72 |
| Working Capital Days | ||||||||||
| Receivable Days | 71.10 | 66.80 | 66.90 | 68.10 | 66.10 | 60.10 | 53.80 | 49.30 | 55.80 | 67.30 |
| Inventory Days | 131.70 | 124.70 | 155.20 | 147.80 | 135.80 | 142.70 | 137.10 | 138.80 | 138.50 | 128.60 |
| Payable Days | 111.60 | 116.20 | 131.60 | 102.60 | 114 | 124.30 | 110.50 | 118.60 | 140.30 | 130.80 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Insecticides (India) Ltd FAQs
The current trading price of Insecticides India on 11-Sep-2026 16:59 is ₹604.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Insecticides India stood at ₹1,758.4 Cr
The latest P/E ratio of Insecticides India as of 10-Sep-2026 is 14.61.
The latest P/B ratio of Insecticides India as of 10-Sep-2026 is 1.40.
The 52-week high of Insecticides India is ₹800.2 and the 52-week low is ₹525.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Insecticides India is ₹2,069 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Insecticides (India) Ltd is a good quality company.
The key valuation ratios of Insecticides (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Insecticides (India) Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Insecticides (India) Ltd
Insecticides (IIL) Company was originally incorporated as Insecticides (India) Private Limited vide on December 18, 1996 under the Companies Act 1956 with the Registrar of Companies NCT of Delhi & Haryana. The company was converted into Public Limited Company on October 29, 2001,
Insecticides (India) has spearheaded the endeavor to bring home world-class quality new generation products through latest technological developments. IIL has entered into technical collaboration with global giants AMVAC, USA for THIMET, which is India's most popular generic pesticide. Thimet, being the first choice of Indian farmers has helped the company in further strengthening its base at the grass root level.
Lap after lap, in this marathon success story, they have weakened the competition to become India’s leading agro-chemical and pesticides manufacturer. The company will soon be starting pesticide-synthesis at Bhiwadi plant. This will help the company in bringing out new products at more competitive prices. Its vision and efforts have ushered in a new era of success and helped IIL to emerge as a formidable player in the Indian agro-chemicals sector. IIL has established a dedicated R&D Center, which is recognized by Department of Scientific & Industrial Research, Ministry of Science and Technology. It focuses on manufacturing high value added, complex new molecules for introduction in the generic market. Though immense efforts have been made, they have far to go. At IIL R&D, they approach each challenge armed with their knowledge of Agri-science & motivated by their commitment to increase crop yield per acre of land.They have taken big steps towards capitalizing on the revolution in crop protection, which is an integral part of holistic crop management.
IIL R&D centre has augmented its infrastructure with sophisticated instruments like HPLC, GLC, AAS, UV and Infrared Spectrophotometer that are used for standardization of manufacturing processes. For production of a wide range of agro-chemicals and pesticides, IIL has set production units at Rajasthan and J&K . These state-of-the-art production facilities offer an integrated environment to ensure optimum performance levels and facilitate production of high quality liquid, granule and powder formulations.
Product range of the company includes:
Crop:
- Lethal
- Thimet
- Lethal super
- Victor
- Sharp
- Kaiser
- Himil
- Milstim
Urban pest:
- Lethal Woodcare
- Lethal Mosquito coils
- Lethal Vaporizer
- Lethal Line
Achievements/ recognition:
- ISO 14001:2004 certification.
You have 21 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
